Tag: #Global Trends

A cyber extortion group has claimed to have exfiltrated over a terabyte of proprietary data from Danish pharmaceutical behemoth Novo... Read more

U.S. Food and Drug Administration staff reviewers announced on Tuesday that immunogenicity data tracking an active immune response to Moderna’s... Read more

Moderna Chief Executive Officer Stephane Bancel told the German business daily Handelsblatt on Wednesday (June 17, 2026) that the United... Read more

Colorado-based biotechnology firm Edgewise Therapeutics has announced that its investigational cardiovascular compound, EDG-7500, successfully met the primary objectives of its... Read more

Eli Lilly and Company has officially announced definitive data from its global Phase 3 BRUIN CLL-322 clinical trial. The landmark... Read more

SK Life Science, Inc. (a Paramus, New Jersey-based biopharmaceutical enterprise and a subsidiary of South Korea's SK Biopharmaceuticals Co., Ltd.)... Read more

Novartis India has officially announced the commercial launch of Pluvicto, marking the country’s premier regulatory-approved radioligand therapy (RLT) indicated for... Read more

Merck & Co. (operating as MSD outside the United States and Canada) has secured formal marketing approval from the U.S.... Read more

Simcere Pharmaceutical Group has formalized a strategic research collaboration agreement with Stanford Medicine to discover and develop novel therapeutic interventions... Read more